美国外科医师学会作者反思：小（≤20毫米）无功能胰腺神经内分泌肿瘤的术前恶性风险评估 - Suppr

ASO Author Reflections: Preoperative Malignant Risk Assessment for Small (≤ 20 mm) Nonfunctioning Pancreatic Neuroendocrine Tumors.

作者信息

Nanno Yoshihide, Toyama Hirochika

机构信息

Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.

出版信息

Ann Surg Oncol. 2023 Jun;30(6):3501-3502. doi: 10.1245/s10434-023-13201-3. Epub 2023 Feb 10.

DOI:10.1245/s10434-023-13201-3

PMID:36765011

Abstract

摘要

相似文献

ASO Author Reflections: Preoperative Malignant Risk Assessment for Small (≤ 20 mm) Nonfunctioning Pancreatic Neuroendocrine Tumors.美国外科医师学会作者反思：小（≤20毫米）无功能胰腺神经内分泌肿瘤的术前恶性风险评估

Ann Surg Oncol. 2023 Jun;30(6):3501-3502. doi: 10.1245/s10434-023-13201-3. Epub 2023 Feb 10.

ASO Author Reflections: Elevated Preoperative Specific Growth Rate is Associated with Shortened Survival After Resection for Pancreatic Neuroendocrine Tumors.ASO作者反思：术前特定生长率升高与胰腺神经内分泌肿瘤切除术后生存期缩短相关。

Ann Surg Oncol. 2020 Oct;27(10):3924-3925. doi: 10.1245/s10434-020-08527-1. Epub 2020 May 28.

ASO Author Reflections: Reconsidering Resection for Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.ASO作者反思：重新审视低分化胰腺神经内分泌癌患者的切除术

Ann Surg Oncol. 2022 Jun;29(6):3532-3533. doi: 10.1245/s10434-022-11479-3. Epub 2022 Feb 26.

ASO Author Reflections: Can We Evaluate Surgical Quality for Pancreatic Neuroendocrine Tumors?美国外科医师学会作者反思：我们能否评估胰腺神经内分泌肿瘤的手术质量？

Ann Surg Oncol. 2024 Jun;31(6):4117-4118. doi: 10.1245/s10434-024-15209-9. Epub 2024 Apr 2.

ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B.ASO作者反思：将G2级胰腺神经内分泌肿瘤分为2A和2B亚级的预后价值

Ann Surg Oncol. 2024 Oct;31(10):7068-7069. doi: 10.1245/s10434-024-15728-5. Epub 2024 Jul 11.

ASO Author Reflections: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors.ASO作者反思：淋巴结状态对胰腺神经内分泌肿瘤术前影像管理的准确性及预后影响

Ann Surg Oncol. 2024 May;31(5):2973-2974. doi: 10.1245/s10434-023-14827-z. Epub 2023 Dec 23.

ASO Author Reflections: Pancreatic Neuroendocrine Tumor Recurrence and Survival Predicted by Ki67.ASO作者反思：Ki67预测胰腺神经内分泌肿瘤的复发和生存情况

Ann Surg Oncol. 2019 Dec;26(Suppl 3):531-532. doi: 10.1245/s10434-018-7019-z. Epub 2018 Dec 5.

ASO Author Reflections: Refining the Surgical Management of Pancreatic Neuroendocrine Tumors.《美国外科医师学会杂志》作者反思：完善胰腺神经内分泌肿瘤的外科治疗

Ann Surg Oncol. 2021 Feb;28(2):1050-1051. doi: 10.1245/s10434-020-09169-z. Epub 2020 Sep 24.

ASO Author Reflections: Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors-A Single Operation is Feasible in Most Patients.ASO作者反思：联合胰腺和肝脏切除术治疗转移性胰腺神经内分泌肿瘤——大多数患者可行单次手术

Ann Surg Oncol. 2022 Oct;29(11):6958-6959. doi: 10.1245/s10434-022-12106-x. Epub 2022 Jul 3.

ASO Author Reflections: Trends in the Number of Lymph Nodes Evaluated Following Resection of Pancreatic Neuroendocrine Tumors-An Increasing Adoption of the AJCC Guidelines?美国外科医师学会作者反思：胰腺神经内分泌肿瘤切除术后评估的淋巴结数量趋势——美国癌症联合委员会（AJCC）指南的采用率是否在上升？

Ann Surg Oncol. 2020 Apr;27(4):1213-1214. doi: 10.1245/s10434-019-08134-9. Epub 2019 Dec 12.

本文引用的文献

Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis.功能性胰腺神经内分泌肿瘤（NF-PanNENs）根治性手术后疾病复发的预测因素：系统评价和荟萃分析。

J Endocrinol Invest. 2022 Apr;45(4):705-718. doi: 10.1007/s40618-021-01705-2. Epub 2021 Nov 13.

Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail.胰体尾腺癌患者术后病理和影像学脾静脉受累是预后不良和早期肝转移的预测因素。

Ann Surg Oncol. 2018 Mar;25(3):638-646. doi: 10.1245/s10434-017-6274-8. Epub 2017 Dec 20.

Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.基于增强特征预测胰腺神经内分泌肿瘤的淋巴结转移。

Pancreatology. 2017 Nov-Dec;17(6):956-961. doi: 10.1016/j.pan.2017.08.003. Epub 2017 Aug 19.

Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis.散发性小（≤20mm）无功能性胰腺神经内分泌肿瘤：采用更保守的策略时，恶性肿瘤的风险是否可以忽略不计？系统评价和荟萃分析。

Ann Surg Oncol. 2017 Sep;24(9):2603-2610. doi: 10.1245/s10434-017-5946-8. Epub 2017 Jul 5.

Pancreatic Duct Involvement in Well-Differentiated Neuroendocrine Tumors is an Independent Poor Prognostic Factor.胰腺导管受累在高分化神经内分泌肿瘤中是一个独立的不良预后因素。

Ann Surg Oncol. 2017 Apr;24(4):1127-1133. doi: 10.1245/s10434-016-5663-8. Epub 2016 Nov 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

ASO Author Reflections: Preoperative Malignant Risk Assessment for Small (≤ 20 mm) Nonfunctioning Pancreatic Neuroendocrine Tumors.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献